The NHS (National Health Service) is to offer people with epilepsy a new form of laser therapy and it could be life-changing for people with uncontrolled focal seizures for whom surgery is considered too risky. Professor John Duncan, former medical director at the Epilepsy Society, has welcomed a new fibre optic laser beam therapy for […]
ARB therapy is associated with a lower risk of subsequently developing epilepsy when compared to drugs from other anti-hypertensives classes Angiotensin receptor blocker (ARB) therapy is associated with a reduced risk of epilepsy development over the next 5 years compared to other anti-hypertensive agents according to a cohort analysis by German researchers. The epilepsies are one of […]
Article In Brief Investigators developed an algorithm that uses clinical and genetic data to help determine the treatment response to antiseizure medications in patients with newly diagnosed epilepsy. Researchers have developed a deep learning model for identifying the best choice of anti-seizure medication for patients with epilepsy, according to findings published online on Aug. 29 […]
A female adult patient with idiopathic generalized epilepsy (IGE) is now the first to receive neuromodular stimulation of the brain to see if it can help with seizures. IGE, which is diagnosed in childhood or adolescence and often results in lifelong seizures, accounts for 15-30% of epilepsies. It is the second most common type of […]
Proton pumps are important enzymes, not only for the stomach, where they maintain the acidity needed to digest food, but elsewhere in the body. Genetic mutations perturbing one type of proton pump have been implicated in several diseases, including myopathy, osteopetrosis and hearing loss. Now Emory neurogeneticist Andrew Escayg, along with colleagues from Montreal, the […]
A new study into “game-changing” long-term seizure-monitoring technology has launched today. The Real World Testing and Cost-effectiveness Analysis of Subcutaneous EEG (REAL-ASE) will recruit 33 people with drug-resistant epilepsy in centers in London, Newcastle, Cardiff and Manchester, to trial the small EEG device for six months. Drug-resistance is when two or more epilepsy medicines have not […]
